Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern Venture Trust Regulatory News (NVT)

Share Price Information for Northern Venture Trust (NVT)

Share Price is delayed by 15 minutes
Get Live Data
55.00    0.00 (0.00%)
Bid:
53.50
Ask:
56.50
Spread: 3.00 (5.607%)
Market Cap: £143.96m
NVT Live PriceLast checked at - London Stock Exchange

Intraday Northern Venture Trust Share Chart

Form 8.3 - NASSTAR PLC

30 Dec 2019 14:00



Form 8.3 - NASSTAR PLC

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Northern Venture Trust PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNasstar plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure30 December 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:6,450,0001.12  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:6,450,0001.12  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:30 December 2019
Contact name:James Bryce
Telephone number*:0191 244 6000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
11th Jun 20263:10 pmBUSStatement regarding intention to fundraise
11th Jun 20263:05 pmBUSDividend Declaration
11th Jun 20263:00 pmBUSAnnual Report and Financial Statements for the year ended 31 March 2026
29th May 20267:00 amBUSTotal Voting Rights
22nd May 20269:59 amRNSHolding(s) in Company
30th Apr 202611:00 amBUSTotal Voting Rights
8th Apr 20263:00 pmBUSAdmission of further securities to trading
2nd Apr 20261:00 pmBUSIssue of Equity and Total Voting Rights
31st Mar 20261:00 pmBUSTotal Voting Rights
27th Mar 20267:00 amBUSTransaction in Own Shares
27th Feb 202611:00 amGNWTotal Voting Rights
23rd Feb 20261:00 pmGNWOffer Update
9th Feb 20267:00 amGNWNet Asset Value
30th Jan 202611:00 amGNWTotal Voting Rights
27th Jan 20262:00 pmGNWAdmission of further shares to trading
21st Jan 202611:00 amGNWIssue of Equity and Total Voting Rights
31st Dec 202511:00 amRNSTotal Voting Rights
31st Dec 202511:00 amGNWTotal Voting Rights
18th Dec 202512:30 pmRNSIssue of Supplementary Prospectus
18th Dec 202512:30 pmGNWIssue of Supplementary Prospectus
8th Dec 202511:00 amGNWProposed increase in size of offer for subscription and re-opening of offer for subscription to further applications
8th Dec 202511:00 amGNWProposed increase in size of offer for subscription
8th Dec 202511:00 amGNWProposed increase in size of offer for subscription and re-opening of offer for subscription to further applications
8th Dec 20257:00 amGNWTransaction in Own Shares
2nd Dec 20257:00 amGNWOffer Update
1st Dec 202511:15 amGNWTotal Voting Rights
25th Nov 20259:00 amGNWDirector/PDMR Dealings
25th Nov 20258:00 amGNWIssue of Equity and Total Voting Rights
20th Nov 20253:15 pmGNWDividend Declaration
20th Nov 20253:15 pmGNWUnaudited half-yearly financial report for the six months ended 30 September 2025
5th Nov 20257:00 amGNWOffer Update - utilisation of over-allotment facility
31st Oct 20257:00 amGNWTotal voting rights
3rd Oct 202510:00 amGNWPortfolio Update - The Beauty Tech Group IPO
30th Sep 20254:30 pmGNWTotal voting rights
29th Sep 20252:00 pmGNWTransaction in Own Shares
24th Sep 20258:00 amGNWOffer for subscription
17th Sep 20253:00 pmGNWPublication of Prospectus
5th Sep 20258:00 amGNWIssue of Equity and Total Voting Rights
1st Sep 20257:00 amGNWTotal voting rights
27th Aug 20251:00 pmGNWTransaction in Own Shares
8th Aug 20257:00 amGNWNet Asset Value(s)
5th Aug 20254:00 pmGNWResult of AGM
31st Jul 202511:00 amGNWTotal voting rights
25th Jul 20257:00 amGNWAnnual Financial Report and Notice of AGM
3rd Jul 20257:00 amGNWTransaction in Own Shares
30th Jun 202511:00 amGNWTotal voting rights
17th Jun 20254:25 pmGNWStatement regarding intention to fundraise
17th Jun 20254:25 pmGNWDividend Declaration
17th Jun 20254:25 pmGNWAnnual Report and Financial Statements for the year ended 31 March 2025
30th May 20257:00 amGNWTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.